Last updated: August 30, 2022
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Rheumatoid Arthritis
Joint Injuries
Dermatomyositis (Connective Tissue Disease)
Treatment
N/AClinical Study ID
NCT05527158
52018
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- meet the RA criteria by the American College of Rheumatology(ACR)/the European LeagueAgainst Rheumatism(EULAR) in 2010 or the ACR in 1987
- between the ages of 18 and 65, regardless of gender
- DAS28≤3.2
- joint function in grades I to II or X-ray in stages I to II
- no use or maintenance of a stable dose of DMARDs, biological agents, or hormoneswithin 4 weeks prior to screening
- wrist joints or finger joints (MCP, PIP) were swollen or painful
- tested for hand dysfunction by a professional rheumatologist
- volunteer to participate
Exclusion
Exclusion Criteria:
- Yijinjing exercise experience within the last 3 months
- severe joint deformity (including subluxation and severe ulnar deviation) and jointankylosis
- other diseases affecting limb function such as trauma, fractures, infections, tumors,congenital malformations
- present with complication diseases such as serious cardiovascular, brain, liver, lung,kidney, and hematopoietic system diseases
- a moderate or severe cognitive impairment that unable to cooperate with the treatment
- unwilling to join
Study Design
Total Participants: 66
Study Start date:
November 01, 2021
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, 100053
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.